Estimating treatment effects in randomised controlled trials with non-compliance: A simulation study

BMJ Open

Volumn 4, Issue 6, 2014, Pages

  Ye, Chenglin ^a,b   Beyene, Joseph ^a   Browne, Gina ^a   Thabane, Lehana ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE ACCESS; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; INTENTION TO TREAT ANALYSIS; PROTOCOL COMPLIANCE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIMULATION; STATISTICAL BIAS; THERAPY EFFECT; TREATMENT REFUSAL; COMPUTER SIMULATION; PATIENT COMPLIANCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84903142721     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005362     Document Type: Article

References (26)

1. McMahon AD. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials. Stat Med 2002;21:1365-76. (Pubitemid 34495605)
2. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Clin Epidemiol 2009;62:499-505.
3. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials. JAMA 2003;290:1624-32.
4. Ye C, Browne G, Beyene J, et al. A sensitivity analysis of the Children's Treatment Network trial: a randomized controlled trial of integrated services versus usual care for children with special health care needs. Clin Epidemiol 2013;5:373-85.
5. Hubbard W. ICH: guidance on statistical principles for clinical trials (FDA Docket No. 97D-0174). Fed Regist 1998;63:49583-98.
6. Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995;57:6-15.
7. Nich C, Carroll KM. 'Intention-to-treat' meets 'missing data': implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend 2002;68:121-30. (Pubitemid 35247784)
8. Wright C, Sim J. Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis. J Clin Epidemiol 2003;56:833-42. (Pubitemid 37162657)
9. Hernán MA, Hernández-Diaz S. Beyond the intention-to-treat in comparative effectiveness research. Clin Trials 2012;9:48-55.
10. Dodd S, White IR, Williamson P. Nonadherence to treatment protocol in published randomised controlled trials: a review. Trials 2012;13:84.
11. Rubin DB. Practical implications of modes of statistical inference for causal effects and the critical role of the assignment mechanism. Biometrics 1991;47:1213-34.
12. Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res 2005;14:369-95. (Pubitemid 41300812)
13. Martens EP, Pestman WR, de Boer A, et al. Instrumental variables: application and limitations. Epidemiology 2006;17:260-7.
14. Jo B. Estimation of intervention effects with noncompliance: alternative model specifications. J Educ Behav Stat 2002;27:385-409. (Pubitemid 36385301)
15. Little RJ, Long Q, Lin X. A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance. Biometrics 2009;65:640-9.
16. Robin JM. Correction for non-compliance in equivalence trials. Stat Med 1998;17:269-302.
17. Bang H, Davis CE. On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions? Stat Med 2007;26:954-64. (Pubitemid 46291124)
18. McNamee R. Intention to treat, per protocol, as treated and instrumental variable estimators given non-compliance and effect heterogeneity. Stat Med 2009;28:2639-52.
19. Sheng D, Kim MY. The effects of non-compliance on intent-to-treat analysis of equivalence trials. Stat Med 2006;25:1183-99.
20. Hertogh EM, Schuit AJ, Peeters PH, et al. Noncompliance in lifestyle intervention studies: the instrumental variable method provides insight into the bias. J Clin Epidemiol 2010;63:900-6.
21. Burton A, Altman DG, Royston P, et al. The design of simulation studies in medical statistics. Stat Med 2006;25:4279-92. (Pubitemid 46023772)
22. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444-55. (Pubitemid 126412813)
23. Atun R, de Jongh T, Secci F, et al. A systematic review of the evidence on integration of targeted health interventions into health systems. Health Policy Plann 2010;25:1-14.
24. Düsing R, Lottermoser K, Mengden T. Compliance with drug therapy - new answers to an old question. Nephrol Dial Transplant 2001;16:1317-21. (Pubitemid 32640580)
25. Yau LHY, Little RJ. Inference for the complier-average causal effect from longitudinal data subject to noncompliance and missing data, with application to a job training assessment for the unemployed. J Am Stat Assoc 2001;96:1232-44. (Pubitemid 33695578)
26. Ye C, Giangregorio L, Holbrook A, et al. Data withdrawal in randomized controlled trials: defining the problem and proposing solutions: a commentary. Contemp Clin Trials 2011;13:318-22.